A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment

CMT1A is the most common inherited peripheral neuropathy. There is currently no approved treatment. We performed a meta-analysis including four randomized, double-blind, Placebo-controlled clinical trials to assess the disease progression after one year under Placebo, Ascorbic Acid (AA) or PXT3003,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Orphanet J Rare Dis
Main Authors: Mandel, Jonas, Bertrand, Viviane, Lehert, Philippe, Attarian, Shahram, Magy, Laurent, Micallef, Joëlle, Chumakov, Ilya, Scart-Grès, Catherine, Guedj, Mickael, Cohen, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Letter to the Editor
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4482281/
https://ncbi.nlm.nih.gov/pubmed/26070802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-015-0293-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados